Collagen VI myopathies: from the animal model to the clinical trial

Adv Enzyme Regul. 2009;49(1):197-211. doi: 10.1016/j.advenzreg.2008.12.009. Epub 2009 Jan 6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Clinical Trials as Topic*
  • Collagen Type VI / genetics
  • Collagen Type VI / metabolism*
  • Collagen Type VI / ultrastructure
  • Cyclosporine / pharmacology
  • Cyclosporine / therapeutic use
  • Disease Models, Animal*
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Extracellular Matrix / metabolism
  • Extracellular Matrix / ultrastructure
  • Humans
  • Mitochondria / metabolism
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / ultrastructure
  • Muscular Diseases / drug therapy
  • Muscular Diseases / genetics*
  • Muscular Diseases / pathology
  • Muscular Diseases / physiopathology*
  • Mutation

Substances

  • Collagen Type VI
  • Enzyme Inhibitors
  • Cyclosporine